Acurx Pharmaceuticals (ACXP) Misses Q2 EPS by 171c
Tweet
Share
E-mailGet Alerts ACXP Hot Sheet
Join SI Premium – FREE
Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q2 EPS of ($1.89), $1.71 worse than the analyst estimate of ($0.18).
For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
- RBC Capital Starts 10X Genomics (TXG) at Sector Perform
- JPMorgan Upgrades Reckitt Benckiser (RKT:LN) (RBGLY) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
